http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-450207-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4beef0c137d9094e6918ee382be22f
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-44
filingDate 1976-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-450207-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF NEW SALTS OF 4,5-DIHIDRO-2-ALCOXICARBONIL-AMINO-4-ARIL-IMIDAZOLES.
abstract A procedure for the preparation of new pharmaceutically acceptable 4,5-dihydro-2-alkoxycarbonylamino-4-aryl-imidazoles salts of the formula: **(See formula)** where R is lower alkyl; R1 or R2 is hydrogen, hydroxy, lower alkyl, lower alkoxy, fluorine, chlorine, bromine, iodine or trifluoromethyl and the other is hydrogen, or the same group as the other of R1 or R2 and where R1 and R2 can be in any different position on the phenyl ring, or R1 and R2 together form the methylenedioxy group and are on adjacent carbon atoms in the phenyl ring, characterized in that procedure because it consists in reacting a compound represented by said formula (I) with an organic acid or pharmaceutically acceptable inorganic hydrogen anion to form said pharmaceutically acceptable hydrogen ion addition salt. (Machine-translation by Google Translate, not legally binding)
priorityDate 1975-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 31.